Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1976 1
1979 4
1980 5
1981 10
1982 11
1983 13
1984 8
1985 13
1986 29
1987 20
1988 24
1989 28
1990 28
1991 40
1992 39
1993 52
1994 53
1995 81
1996 70
1997 89
1998 78
1999 63
2000 113
2001 123
2002 123
2003 145
2004 179
2005 226
2006 276
2007 305
2008 377
2009 399
2010 519
2011 600
2012 731
2013 842
2014 1015
2015 1171
2016 1241
2017 1409
2018 1731
2019 2005
2020 2376
2021 2689
2022 274
Text availability
Article attribute
Article type
Publication date

Search Results

17,547 results
Results by year
Filters applied: . Clear all
Page 1
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes.
Liu SY, Bao H, Wang Q, Mao WM, Chen Y, Tong X, Xu ST, Wu L, Wei YC, Liu YY, Chen C, Cheng Y, Yin R, Yang F, Ren SX, Li XF, Li J, Huang C, Liu ZD, Xu S, Chen KN, Xu SD, Liu LX, Yu P, Wang BH, Ma HT, Yan HH, Dong S, Zhang XC, Su J, Yang JJ, Yang XN, Zhou Q, Wu X, Shao Y, Zhong WZ, Wu YL. Liu SY, et al. Among authors: xu st, xu sd, xu s. Nat Commun. 2021 Nov 8;12(1):6450. doi: 10.1038/s41467-021-26806-7. Nat Commun. 2021. PMID: 34750392 Free PMC article. Clinical Trial.
Diffusion and convection in nature.
Vailati A, Xu S, Aime S, Croccolo F. Vailati A, et al. Among authors: xu s. Eur Phys J E Soft Matter. 2021 Nov 30;44(12):145. doi: 10.1140/epje/s10189-021-00148-0. Eur Phys J E Soft Matter. 2021. PMID: 34850315 Free PMC article.
Natural Products and Cardiovascular Diseases.
Tian K, Xu S. Tian K, et al. Among authors: xu s. Curr Mol Pharmacol. 2021;14(6):923-924. doi: 10.2174/187446721406211220144326. Curr Mol Pharmacol. 2021. PMID: 35018881 No abstract available.
CMTM6, a potential immunotherapy target.
Liang J, Li S, Li W, Rao W, Xu S, Meng H, Zhu F, Zhai D, Cui M, Xu D, Cai J, Zhang B. Liang J, et al. Among authors: xu s. J Cancer Res Clin Oncol. 2022 Jan;148(1):47-56. doi: 10.1007/s00432-021-03835-9. Epub 2021 Nov 16. J Cancer Res Clin Oncol. 2022. PMID: 34783871 Review.
Obesity and insulin resistance: Pathophysiology and treatment.
Tong Y, Xu S, Huang L, Chen C. Tong Y, et al. Among authors: xu s. Drug Discov Today. 2021 Nov 9:S1359-6446(21)00479-7. doi: 10.1016/j.drudis.2021.11.001. Online ahead of print. Drug Discov Today. 2021. PMID: 34767960 Review.
Multi-membrane search algorithm.
Song Q, Huang Y, Lai W, Han T, Xu S, Rong X. Song Q, et al. Among authors: xu s. PLoS One. 2021 Dec 6;16(12):e0260512. doi: 10.1371/journal.pone.0260512. eCollection 2021. PLoS One. 2021. PMID: 34871309 Free PMC article.
Emerging nanomedicines of paclitaxel for cancer treatment.
Chen Q, Xu S, Liu S, Wang Y, Liu G. Chen Q, et al. Among authors: xu s. J Control Release. 2022 Jan 10;342:280-294. doi: 10.1016/j.jconrel.2022.01.010. Online ahead of print. J Control Release. 2022. PMID: 35016919 Review.
17,547 results
You have reached the last available page of results. Please see the User Guide for more information.